Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Mar;141(3):457-66.
doi: 10.1111/imm.12208.

Protection against collagen-induced arthritis in mice afforded by the parasitic worm product, ES-62, is associated with restoration of the levels of interleukin-10-producing B cells and reduced plasma cell infiltration of the joints

Affiliations

Protection against collagen-induced arthritis in mice afforded by the parasitic worm product, ES-62, is associated with restoration of the levels of interleukin-10-producing B cells and reduced plasma cell infiltration of the joints

David T Rodgers et al. Immunology. 2014 Mar.

Abstract

We have previously reported that ES-62, a molecule secreted by the parasitic filarial nematode Acanthocheilonema viteae, protects mice from developing collagen-induced arthritis (CIA). Together with increasing evidence that worm infection may protect against autoimmune conditions, this raises the possibility that ES-62 may have therapeutic potential in rheumatoid arthritis and hence, it is important to fully understand its mechanism of action. To this end, we have established to date that ES-62 protection in CIA is associated with suppressed T helper type 1 (Th1)/Th17 responses, reduced collagen-specific IgG2a antibodies and increased interleukin-10 (IL-10) production by splenocytes. IL-10-producing regulatory B cells have been proposed to suppress pathogenic Th1/Th17 responses in CIA: interestingly therefore, although the levels of IL-10-producing B cells were decreased in the spleens of mice with CIA, ES-62 was found to restore these to the levels found in naive mice. In addition, exposure to ES-62 decreased effector B-cell, particularly plasma cell, infiltration of the joints, and such infiltrating B cells showed dramatically reduced levels of Toll-like receptor 4 and the activation markers, CD80 and CD86. Collectively, this induction of hyporesponsiveness of effector B-cell responses, in the context of the resetting of the levels of IL-10-producing B cells, is suggestive of a modulation of the balance between effector and regulatory B-cell responses that may contribute to ES-62-mediated suppression of CIA-associated inflammation and inhibition of production of pathogenic collagen-specific IgG2a antibodies.

Keywords: ES-62; interleukin-10-producing B cells; parasitic helminths; rheumatoid arthritis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Gating strategy for analysis of B-cell subsets and phenotyping of populations. This is a modification of that based on the peripheral B cell phenotypic markers defined by Allman and Pillai. T1: CD19+ CD93+ CD21int CD23 IgDlow/− IgMhigh; T2: CD19+ CD93+ CD21int CD23+ IgDhigh IgMhigh; T3: CD19+ CD93+ CD21int CD23+ IgDhigh IgMlow; marginal zone precursor (MZP): CD19+ CD93 CD21high CD23+ CD1dhigh IgDhigh IgMhigh; marginal zone (MZ): CD19+ CD93 CD21high CD23 CD1dhigh IgDlow/ IgMhigh; Fo1: CD19+ CD93 CD21low CD23+ IgDhigh IgMlow; Fo2: CD19+ CD93 CD21low CD23+ IgDhigh IgMhigh; GC: CD19+ CD43 CD24+ GL7+. Cell populations were initially selected on the basis of ‘Lymphocyte’ size (forward scatter; FSC) and granularity (side scatter; SSC) parameters and excluding ‘doublets’ (by comparing FSC-Height and FSC-Area) and dead cells (by the Live/Dead® fixable aqua dead cell dye; Invitrogen) (data not shown). We initially gated on CD19+ CD23 and CD19+ CD23+ cells (a) to resolve MZP (CD21high CD1dhigh) from follicular (Fo) (CD21low CD1dlow) B cells (b) and MZ (CD21+ IgM+) and T1 (CD21 IgM+) cells (c), respectively. The Fo population identified (b; CD21low CD1dlow) is a heterogeneous population that contains the functionally distinct follicular type 1 (Fo1: IgDhigh IgMlow AA4·1) and follicular type 2 (Fo2: IgDhigh IgMhigh AA4·1) as well as the transitional 2 (T2: IgDhigh IgMhigh AA4·1+) and transitional 3 (T3: IgDhigh IgMlow AA4·1+) populations. These populations are first separated on the basis of their expression of IgM and IgD (d) and then, AA4·1 (e,f). For the identification of germinal centre (GC) B cells we first identify CD19+ CD43 cells (g) and then exclude contaminating non-B cells by gating on the GC cell-specific marker GL7 along with the pan-B-cell marker CD24 (h) before confirming expression of FAS (i) by essentially all (> 90%) CD19+ CD43 CD24+ GL7+ GC B cells; we have therefore not included this redundant marker in our analysis.
Figure 2
Figure 2
ES-62 reduces the levels of germinal centre B cells in the spleens of mice with collagen-induced arthritis (CIA). Mean articular scores (±SEM) of CIA mice treated with PBS (= 34) or ES-62 (= 18) at time of cull at day 28 (a). The percentage of CD19+ B cells (b); representative plots (c) and proportions (d; mean values ± SEM of individual mice where naive, = 16; PBS, = 31; ES-62, = 12) of marginal zone precursor (MZP), marginal zone (MZ) and follicular (Fo) B cells as defined by their expression of CD21 and CD23; Follicular type 1 B cells (Fo1, e: CD19+ CD23+ CD21low CD1dlow IgMlow IgDhigh AA4·1) and germinal centre cells (GC; f: CD19+ CD43 CD24+ GL7+), as derived by the gating strategy presented in Fig. 1, in spleens from mice undergoing CIA are shown.
Figure 3
Figure 3
ES-62 modulates the recruitment of B cells to the joints of mice with collagen-induced arthritis (CIA). Cells extracted from the joints of mice with CIA were analysed for the proportion (a,b) and number (c) of infiltrating CD19+ B cells (data in c are presented as the means ± SEM of four biological replicates pooled from two independent experiments) and consequently for the relative proportions of CD19+ CD23+ (d,e) and plasma cells on the basis of CD19 CD138 expression (f,g). Exclusion of myeloid and T-cell-expressing CD138 cells by use of Dump channel (CD4+ CD8+ GR1+ F4/80+ CD11b+ CD11c+; h) allowed analysis of Dump CD19 B220 CD138+ and Dump CD19+ B220low/− CD138+ plasma cells (i,j).
Figure 4
Figure 4
ES-62 modulates expression of Toll-like receptor 4 (TLR4) and co-stimulatory molecules on Follicular B cells. CD80, CD86, TLR4 and BAFF-R expression by CD19+ CD23high CD21low follicular B cells in the joints of PBS and ES-62 treated mice are presented as expression levels relative to isotype control (grey area), for CIA mice treated with PBS (broken line) or ES-62 (black line). Cells from at least five mice/group were pooled.
Figure 5
Figure 5
ES-62 modulates the levels of B1-like cells in the spleen and LNs of mice with collagen-induced arthritis (CIA). There is no unambiguous phenotype for B1 cells in the spleen but they have been described as CD19high CD23 CD43+ IgMhigh IgDlow/− CD5± cells where CD5+ B1a and CD5 B1b comprise ˜2% and 1% of cells in the spleen, respectively. However, following gating on CD19+ IgM+ (a), analysis of CD43+ CD5± cells has been widely used to describe B1 cells, whereas CD19+ CD5+ gating has been used to describe B1a cells. Moreover, although CD43 can be up-regulated on B2 cells, this is usually expressed at a lower level than on B1 cells and we have therefore chosen to gate only on CD43high cells (b) so as to exclude any potential CD43+ B2 cells. We have therefore phenotyped CD19high CD43+ IgMhigh B cells as CD5+ B1a-like cells and CD5 B1b-like cells and the data show their relative proportions in the spleen (c; naive, n = 10; PBS, n = 13 and ES-62, n = 11) and draining lymph node (d; naive, n = 4; PBS, n = 8 and ES-62, n = 8) of the indicated groups of mice.
Figure 6
Figure 6
ES-62 induces interleukin-10 (IL-10)-producing B cells in the spleen of mice with collagen-induced arthritis (CIA). IL-10-producing CD19+ B cell (a,c) and IL-10-producing CD19 non-B-cell subsets (a,d) in the spleen were analysed with the proportions of these cells, in spleens of individual naive mice and PBS- and ES-62-treated mice with CIA, shown respectively. Representative plots of the phenotypes of CD19+ IL-10+ B cells based on their expression of CD21 and CD23 (b) are shown for spleens of mice with CIA.

Similar articles

Cited by

References

    1. Panda AK, Ravindran B, Das BK. Rheumatoid arthritis patients are free of filarial infection in an area where filariasis is endemic: comment on the article by Pineda et al. Arthritis Rheum. 2013;65:1402–3. - PubMed
    1. Harnett W, Harnett MM. Reply: comment on Rheumatoid arthritis patients are free of filarial infection in an area where filariasis is endemic: comment on the article by Pineda et al [Arthritis Rheum. 2013] The parasitic helminth product ES-62 suppresses pathogenesis in collagen-induced arthritis by targeting the interleukin-17-producing cellular network at multiple sites. [Arthritis Rheum. 2012] Arthritis Rheum. 2013;65:1403–4. - PubMed
    1. Harnett W, Harnett MM. Helminth-derived immunomodulators: can understanding the worm produce the pill? Nat Rev Immunol. 2010;10:278–84. - PubMed
    1. Pineda MA, McGrath MA, Smith PC, Al-Riyami L, Rzepecka J, Gracie JA, Harnett W, Harnett MM. The parasitic helminth product ES-62 suppresses pathogenesis in CIA by targeting of the IL-17-producing cellular network at multiple sites. Arthritis Rheum. 2012;64:3168–78. - PubMed
    1. Mauri C, Ehrenstein MR. Cells of the synovium in rheumatoid arthritis. B cells. Arthritis Res Ther. 2007;9:205. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources